Statin use vs. average non-HDL cholesterol levels in Vanuatu

Vanuatu: Statin use vs. average non-HDL cholesterol levels was 3.6 in 2018. ▲ Rising

Latest (2018)
3.6
Change on year
unchanged
World rank
30th
of 191 countries
All-time high
3.6
in 2008
All-time low
3.2
in 1980
Years of data
39
1980–2018

Statin use vs. average non-HDL cholesterol levels in Vanuatu, 1980–2018

012341980199920181980: 3.21981: 3.31982: 3.31983: 3.31984: 3.31985: 3.31986: 3.31987: 3.41988: 3.41989: 3.41990: 3.41991: 3.41992: 3.41993: 3.51994: 3.51995: 3.51996: 3.51997: 3.51998: 3.51999: 3.52000: 3.52001: 3.52002: 3.52003: 3.52004: 3.52005: 3.52006: 3.52007: 3.52008: 3.62009: 3.62010: 3.62011: 3.62012: 3.62013: 3.62014: 3.62015: 3.62016: 3.62017: 3.62018: 3.6

Source: World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data.

Analysis

In 2018, statin use vs. average non-hdl cholesterol levels in Vanuatu stood at 3.6. That is the highest value across all 39 years on record.

The figure is unchanged over ten years.

Over the whole period, statin use vs. average non-hdl cholesterol levels in Vanuatu peaked at 3.6 in 2008 and was at its lowest, 3.2, in 1980.

That places Vanuatu 30th out of 191 countries with data for 2018, putting it in the top quarter.

The long-run direction has been consistently rising across the 39 years of available data.

Statin use vs. average non-HDL cholesterol levels in Vanuatu, year by year

Annual values for Statin use vs. average non-HDL cholesterol levels in Vanuatu, 1980 to 2018.
Year Value Change
1980 3.2
1981 3.3 +3.1%
1982 3.3 +0.0%
1983 3.3 +0.0%
1984 3.3 +0.0%
1985 3.3 +0.0%
1986 3.3 +0.0%
1987 3.4 +3.0%
1988 3.4 +0.0%
1989 3.4 +0.0%
1990 3.4 +0.0%
1991 3.4 +0.0%
1992 3.4 +0.0%
1993 3.5 +2.9%
1994 3.5 +0.0%
1995 3.5 +0.0%
1996 3.5 +0.0%
1997 3.5 +0.0%
1998 3.5 +0.0%
1999 3.5 +0.0%
2000 3.5 +0.0%
2001 3.5 +0.0%
2002 3.5 +0.0%
2003 3.5 +0.0%
2004 3.5 +0.0%
2005 3.5 +0.0%
2006 3.5 +0.0%
2007 3.5 +0.0%
2008 3.6 +2.9%
2009 3.6 +0.0%
2010 3.6 +0.0%
2011 3.6 +0.0%
2012 3.6 +0.0%
2013 3.6 +0.0%
2014 3.6 +0.0%
2015 3.6 +0.0%
2016 3.6 +0.0%
2017 3.6 +0.0%
2018 3.6 +0.0%

Vanuatu compared with similar countries

  • Vanuatu's 3.6 is above the median for lower middle income countries, which is 3.1, 1.2× the median. (46 countries reporting)
  • Vanuatu's 3.6 is above the median for East Asia & Pacific, which is 3.5, 1.0× the median. (30 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
1980s 3.32 3.2 3.4 10
1990s 3.47 3.4 3.5 10
2000s 3.52 3.5 3.6 10
2010s 3.6 3.6 3.6 9

Countries ranked near Vanuatu

  1. 30 Albania 3.6 compare
  2. 30 Andorra 3.6 compare
  3. 30 Austria 3.6 compare
  4. 30 Bulgaria 3.6 compare
  5. 30 Dominican Republic 3.6 compare
  6. 30 Estonia 3.6 compare
  7. 30 Hungary 3.6 compare
  8. 30 Indonesia 3.6 compare
  9. 30 Jamaica 3.6 compare
  10. 30 Jordan 3.6 compare
  11. 30 Montenegro 3.6 compare
  12. 30 North Macedonia 3.6 compare
  13. 30 Papua New Guinea 3.6 compare
  14. 30 Portugal 3.6 compare
  15. 30 Romania 3.6 compare
  16. 30 Russia 3.6 compare
  17. 30 Slovakia 3.6 compare
  18. 30 Slovenia 3.6 compare
  19. 30 Ukraine 3.6 compare
  20. 30 Uruguay 3.6 compare
  21. 30 Uzbekistan 3.6 compare

See the full ranking of 191 places →

More reference data data for Vanuatu

All data for Vanuatu →

Frequently asked questions

What is statin use vs. average non-hdl cholesterol levels in Vanuatu?
Statin use vs. average non-hdl cholesterol levels in Vanuatu was 3.6 in 2018, according to World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data.
What is the highest statin use vs. average non-hdl cholesterol levels recorded in Vanuatu?
The highest recorded value was 3.6 in 2008.
What is the lowest statin use vs. average non-hdl cholesterol levels recorded in Vanuatu?
The lowest recorded value was 3.2 in 1980.
How does Vanuatu rank for statin use vs. average non-hdl cholesterol levels?
Vanuatu ranks 30th out of 191 countries with data for 2018.
Is statin use vs. average non-hdl cholesterol levels rising or falling in Vanuatu?
Over the last ten years it is unchanged. The long-run trend across the full record is rising.
Where does this Vanuatu data come from?
The figures come from World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Statin use vs. average non-HDL cholesterol levels in Vanuatu. Statizoid, drawing on World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data. Retrieved 23 September 2026, from https://reference.statizoid.com/stat/statin-use-vs-average-non-hdl-cholesterol-levels/vanuatu/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/statin-use-vs-average-non-hdl-cholesterol-levels/vanuatu/">Statin use vs. average non-HDL cholesterol levels in Vanuatu</a> — Statizoid

About this data

Indicator
Statin use vs. average non-HDL cholesterol levels
Source
World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.